| Literature DB >> 30186900 |
Mohamed Askar1, Benjamin Bloch2, Roger Bayston1.
Abstract
Prosthetic joint infection is usually caused by staphylococci. Among the coagulase-negative staphylococci, Staphylococcus lugdunensis is important because it behaves as a pathogen similar to S aureus. It also develops biofilms, and the biofilm phenotype can appear as small-colony variants. Although genetically indistinguishable, they differ in size and antibiotic susceptibility from the parent strain and are responsible for chronic persistent infection and failure of antibiotic treatment. They can also lead to misinterpretation of results. The patient reported here underwent total knee replacement and 2 years later presented with prosthetic joint infection. Tissue samples and prosthesis taken at revision grew S lugdunensis, the majority of which were small-colony variants. Recommendations are made for their detection and identification.Entities:
Keywords: Infection; Joint; Prosthetic; Staphylococcus; lugdunensis
Year: 2018 PMID: 30186900 PMCID: PMC6123340 DOI: 10.1016/j.artd.2018.06.003
Source DB: PubMed Journal: Arthroplast Today ISSN: 2352-3441
Figure 1(a) Culture of the sonicate from the removed prosthesis on blood agar after 72 hours of incubation, showing large colonies surrounded by high numbers of very small colonies. The marked square is magnified 10 times in (b) to show the small colonies more clearly.
Summary of S lugdunensis PJI cases reported in the literature.
| Reference | No. | Age (range) | Gender | Comorbidities | Duration | Site |
|---|---|---|---|---|---|---|
| Sampathkumar et al. | 2 | 72 | M | MG, cancer pancreas, asthma | 4 y | TKR |
| 74 | M | Cancer prostate | 6 wk | TKR | ||
| Weightman et al. | 1 | 72 | M | 10 mo | TKR | |
| Sanzeni and Ringberg | 1 | 54 | M | 2 y | THR | |
| Losada et al. | 1 | 69 | M | Rheumatoid arthritis treated with steroids and cyclosporin | TKR | |
| Frank et al. | 6 | |||||
| Lecuire et al. | 7 | (34-86) | From 6 wk up to 9 y and 8 mo | 4 TKR, 3 THR | ||
| Trampuz et al | 3 | |||||
| Shah et al. | 28 | (35-88) | 14 M, 14 F | 3 DM, 5 on steroids, 9 urogenital abnormalities | 25 TKR, 3 THR | |
| Harris et al. | 8 | |||||
| Merino et al. | 1 | 51 | M | Multiple myeloma | 10 y | THR |
| Szabados et al. | 1 | 47 | M | DM, HBV | 2.5 y | THR |
| Tsaras et al. | 3 | |||||
| Tande et al. | 5 | |||||
| Campoccia et al. | 4 | 2 TKR, 2 THR | ||||
| Peel et al. | 7 | |||||
| Marmor et al. | 9 | 6 TKR, 3 THR | ||||
| Lourtet-Hascoet et al. | 28 | (58-78) | 13 M, 15 F | 4 CVD, 2 cancer, 1 DM, 1 rheumatoid disease | 3-56 wk | 16 TKR, 10 THR, 1 foot, 1 shoulder |
| Argemi et al. | 1 | 70 | F | 2 y | TKR |
CVD, cardiovascular disease; DM, diabetes mellitus; F, female; HBV, hepatitis B; M, male; MG, myasthenia gravis; No., number of patients; THR, total hip replacement; TKR, total knee replacement.